Carregant...

Comparison of twice-daily vs once-daily deferasirox dosing in a gerbil model of iron cardiomyopathy

OBJECTIVE: Despite the availability of deferoxamine chelation therapy for more than 20 years, iron cardiomyopathy remains the leading cause of death in thalassemia major patients. Effective chelation of cardiac iron is difficult; cardiac iron stores respond more slowly to chelation therapy and requi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Otto-Duessel, Maya, Aguilar, Michelle, Nick, Hanspeter, Moats, Rex, Wood, John C.
Format: Artigo
Idioma:Inglês
Publicat: 2007
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2892931/
https://ncbi.nlm.nih.gov/pubmed/17588475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.exphem.2007.04.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!